Highlights
- Institutional investors have made adjustments to their holdings in Johnson & Johnson (NYSE:JNJ), reflecting recent portfolio changes.
- Several firms have acquired new positions or increased existing stakes in the company.
- Johnson & Johnson remains a key focus in the healthcare sector among major investment firms.
Institutional investors have been making changes to their holdings in Johnson & Johnson, a key player in the healthcare sector. Various firms have either increased their positions or acquired new stakes, aligning with portfolio adjustments in the latest quarter.
Several financial firms have reported updates to their positions. IFS Advisors LLC increased its stake in Johnson & Johnson by a significant margin, while NewSquare Capital LLC made a similar move. Additionally, firms such as Bay Harbor Wealth Management LLC and RPg Family Wealth Advisory LLC have acquired new positions. These adjustments indicate ongoing activity among institutional stakeholders.
Additional firms have also been involved in modifying their holdings. Activest Wealth Management and NewSquare Capital LLC both expanded their positions in Johnson & Johnson. These moves contribute to the broader trend of institutional participation in the company.
Johnson & Johnson has remained a widely held stock in institutional portfolios. A substantial percentage of its shares are controlled by financial firms, reflecting ongoing interest in the company's standing within the healthcare sector. With continued adjustments among various institutions, the stock remains an area of focus for portfolio strategies.
Institutional ownership continues to play a key role in the stock's market presence. Adjustments among financial firms highlight the evolving landscape of portfolio management, with Johnson & Johnson maintaining its relevance among key stakeholders.